Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Teriparatide before or after dental implant surgery in osteoporotic middle-aged and older adults
ChiCTR2000036741Phase 4Not yet recruiting
- Sponsor
- Ruijin Hospital
- Start
- Oct 2020
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label trial of teriparatide in osteoporosis and edentulism (4 arms), sponsored by Ruijin Hospital. Primary endpoints: Implant stability, Implant looseness and 2 more. Planned start Oct 2020; status: not yet recruiting.
02
Drugs
teriparatide
03
Conditions
osteoporosisedentulism
Beyond the preview
Go deeper on ChiCTR2000036741.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000036741.